Prodotti Pediatria

Una linea di Prodotti studiata per fornire un delicato approccio per la Detersione cutanea e l’Igiene intima del bambino, per fornire un’ottimale Idratazione e Protezione in caso di arrossamenti, screpolature, dermatite atopica ecc. La linea comprende anche prodotti per il trattamento di Ansia, Stress, Agitazione e Insonnia nei bambini, per la prevenzione e il trattamento di lesioni e infezioni del cavo orale e per il trattamento delle prime forme di acne adolescenziale. A completamento della Linea di recente sono stati inseriti due prodotti altamente specifici. Il primo ad azione Immunostimolante e di Ricolonizzazione del Micorbiota intestinale, per fornire una prevenzione a 360 gradi delle patologie stagionali ed il secondo in grado di offrire un approccio combinato e integrato nelle infezioni gastroenteriche.

Tutti i prodotti di questa linea sono costituiti da un’associazione di principi attivi e dosaggi ottimali per garantire un rapido effetto terapeutico.

RSS The Journal of Pediatrics

  • Association of Maternal Immune Activation during Pregnancy and Neurological Outcomes in Offspring May 6, 2021
    To evaluate neurologic morbidity among offspring during their first year of life in association with prenatal maternal immune activation (MIA), using an inclusive definition.
    Samhita Jain, Rebecca J. Baer, Charles E. McCulloch, Elizabeth Rogers, Larry Rand, Laura Jelliffe-Pawlowski, Xianhua Piao
  • Reply May 4, 2021
    To the Editor, The authors show histologic images from an excised median raphe cyst in a young boy. To even a humble pediatric urologist, the representative histology shows a cystic space lined with epithelium. This arrangement explains why this embryologic fusion abnormality is unlikely to spontaneous resolve with time. As such, these histology images represent […]
    Christopher E. Bayne
  • Children victims of witnessing domestic and family violence: a widespread occurrence during COVID-19 pandemic May 4, 2021
    All across the world, youngsters are daily exposed to toxic levels of violent behaviors, including domestic and family violence. During recent years, violence has increasingly permeated and profoundly affected the lives of children as the most vulnerable members of society1. Pediatric societies in Europe and the US raised great concern over the effect that abusive […]
    Pietro Ferrara, Giulia Franceschini, Giovanni Corsello, Julije Mestrovic, Ida Giardino, Mehmet Vural, Tudor Lucian Pop, Leyla Namazova-Baranova, Eli Somekh, Flavia Indrio, Massimo Pettoello-Mantovani
  • Final Outcomes of a Pediatric Surge-In-Place Model during the COVID-19 Pandemic May 3, 2021
    We reported our hospital’s approach to ‘surge in place’ – where pediatric providers and nurses cared for adults with COVID-19 on a 40-bed unit within a children’s hospital.(1) We leveraged our existent quality and safety infrastructure to rapidly create and run this unit within our integrated healthcare system. Final outcomes of our first 100 patients […]
    Kaitlyn Philips, Patricia Hametz
  • Hardened Hope: Care Advances for Fibrodysplasia Ossificans Progressiva May 1, 2021
    Yesterday there came a Boy of healthy Look, and about Fourteen Years old, to ask us at the Hospital, what should be done to cure him of many large Swellings on his Back, which began about Three Years since, and have continued to grow large on many Parts as a Peny-loaf, particularly on the Left […]
    Peter Kannu, Charles E. Levy
  • Improving the Diagnosis of Fibrodysplasia Ossificans Progressiva May 1, 2021
    Fibrodysplasia ossificans progressiva (FOP) is a distinctive but often-overlooked disorder, owing to its extreme rarity and insidious presentation. However, the signs of classic FOP are evident at birth, and the disease clinically manifests typically within the first decade of life. The characteristic and invariably early sign of FOP is congenital malformation of the great toes […]
    Peter Kannu, Charles E. Levy
  • Table of Contents May 1, 2021
  • Evolving Management of Fibrodysplasia Ossificans Progressiva May 1, 2021
    At present, there are no approved treatments for FOP that can reverse the condition or prevent heterotopic ossification, the abnormal growth of bone in soft tissues and muscles.1 Current goals of FOP management are supportive and focus on prevention and management of disease flare-ups, delay of heterotopic ossification, and improvement of the quality of life […]
    Peter Kannu, Charles E. Levy
  • CME Pages May 1, 2021
  • Supplement Title Page May 1, 2021